Telos Biotech and Made Scientific Partner to Advance TELOVANCEâ„¢ Evaluation
DALLAS, Texas & PRINCETON, N.J. | June 19, 2026 Telos Biotech, Inc. has announced a strategic evaluation collaboration with...
AI drug discovery artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Device Medical Devices Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine targeted therapy
DALLAS, Texas & PRINCETON, N.J. | June 19, 2026 Telos Biotech, Inc. has announced a strategic evaluation collaboration with...
BOSTON, Mass., May 8, 2026 Ensoma announced the presentation of initial clinical safety data from the first participant dosed...
CRANFORD, N.J., March 31, 2026 Citius Oncology, Inc. has reported strong early momentum following the U.S. launch of its...
Miami, Florida — February 6, 2026 CaseBioscience® has announced the launch of CaseCryo® CTG DMSO and CaseStor® HSS Hypothermic...
